Metagenomics Market Report 2026

Metagenomics Market Report 2026
Global Outlook – By Product (Instruments, Kits And Reagents, Software And Services), By Workflow (Sequencing, Pre-Sequencing, Data Analysis), By Application (Environmental, Clinical Diagnostics, Drug Discovery, Biotechnology, Food And Nutrition, Other Applications), By End User (Pharmaceutical Industries, Research Laboratories, Biotechnology Companies, Pathology Laboratories, Academic And Research Institutes) - Market Size, Trends, And Global Forecast 2026-2035
Metagenomics Market Overview
• Metagenomics market size has reached to $2.31 billion in 2025 • Expected to grow to $4.58 billion in 2030 at a compound annual growth rate (CAGR) of 14.7% • Growth Driver: Metagenomics Market Driven By The Growing Agriculture Sector • Market Trend: Advancements In Human Microbiome Sequencing Enable Fully Automated, High-Throughput Analysis • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Metagenomics Market?
Metagenomics refers to a field of scientific research that involves the study of genetic material (DNA or RNA) obtained directly from environmental samples or complex microbial communities. It focuses on analyzing the collective genomic information present in a sample rather than isolating and studying individual organisms. The main types of products involved in metagenomics are instruments, kits and reagents, and software and services. Instruments refer to the tools and equipment used for sample collection, DNA, and RNA extraction. It includes several types of workflows, such as sequencing, pre-sequencing, and data analysis, and is used for several applications, including environmental, clinical diagnostics, drug discovery, biotechnology, food and nutrition, and others. These are used by various end-users, such as pharmaceutical industries, research laboratories, biotechnology companies, pathology laboratories, and academic and research institutes.
What Is The Metagenomics Market Size and Share 2026?
The metagenomics market size has grown rapidly in recent years. It will grow from $2.31 billion in 2025 to $2.65 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increasing sequencing adoption, rising microbial diversity studies, growth in environmental microbiology research, expanding pcr machine availability, rising clinical diagnostic usage.What Is The Metagenomics Market Growth Forecast?
The metagenomics market size is expected to see rapid growth in the next few years. It will grow to $4.58 billion in 2030 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to advancement in sequencing technologies, growing demand for microbiome-based therapeutics, increasing r&d in bioinformatics, rising investment in environmental monitoring, expansion of precision medicine applications. Major trends in the forecast period include expansion of precision genomics for microbial community profiling, AI-enhanced metagenomic data interpretation, automation in metagenomic sample processing, cloud-based storage for large-scale sequencing data, iot-integrated environmental microbial monitoring.Global Metagenomics Market Segmentation
1) By Product: Instruments, Kits And Reagents, Software And Services 2) By Workflow: Sequencing, Pre-Sequencing, Data Analysis 3) By Application: Environmental, Clinical Diagnostics, Drug Discovery, Biotechnology, Food And Nutrition, Other Applications 4) By End User: Pharmaceutical Industries, Research Laboratories, Biotechnology Companies, Pathology Laboratories, Academic And Research Institutes Subsegments: 1) By Instruments: DNA Sequencers, PCR Machines, Microarray Systems, Mass Spectrometers 2) By Kits And Reagents: DNA Extraction Kits, Library Preparation Kits, Amplification Kits, Sequencing Reagents 3) By Software And Services: Data Analysis Software, Bioinformatics Services, Cloud-Based Data Storage, Consultation ServicesWhat Is The Driver Of The Metagenomics Market?
The growing agriculture sector is expected to boost the growth of the metagenomics market going forward. The agriculture sector refers to the broad industry involved in cultivating crops, raising livestock, and producing food and other essential agricultural goods that support global economies and food security. The agriculture sector is expanding due to rising global food demand, advancements in sustainable farming, and increased adoption of modern technologies that improve yield and resource efficiency. Metagenomics enhances agricultural productivity by analyzing soil and crop-associated microbial communities, enabling precision farming decisions on soil health, nutrient management, disease control, and environmental sustainability. For instance, in December 2023, according to the U.S. Department of Agriculture Economic Research Service, a U.S.-based government agency, U.S. agricultural exports reached 178.7 billion in 2023, reflecting continued expansion of the agricultural sector and the growing adoption of advanced technologies to support productivity. Therefore, the growing agriculture sector is driving the growth of the metagenomics industry.Key Players In The Global Metagenomics Market
Major companies operating in the metagenomics market are Illumina Inc., Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Novogene Co. Ltd., Oxford Nanopore Technologies Limited, BGI Group, Eurofins Scientific SE, Arc Bio LLC, Computomics GmbH, Enterome Bioscience, TAKARA BIO INC., Danaher Corporation, ELITechGroup, Metagenomi, Cosmosid Inc., Pattern Ag, Tiny Health, MATIS OHF, Adapsyn Bioscience, Precidiag Inc., One Codex Inc., MetaBi Inc., Zymo Research Corporation, Bluebee Holding BV, Maverix Biomics Inc., Lucigen CorporationGlobal Metagenomics Market Trends and Insights
Major companies operating in the metagenomics market are focusing on developing advanced solutions, such as high-throughput sequencing platforms to improve accuracy, efficiency, and reproducibility in microbiome and microbial community analysis. High-throughput sequencing platforms are advanced technologies that can rapidly read and analyze millions of DNA or RNA sequences simultaneously, enabling large-scale genomic or metagenomic studies. For instance, in August 2024, MGI Tech Co. Ltd, a China-based sequencing technology company, launched its Human Microbiome Metagenomics Sequencing Package, which offers high automation across the full workflow from stool collection to data output, flexible throughput options for varied lab sizes, and validated performance across numerous biological sample types for human microbiome research. This package is designed to streamline microbiome studies by integrating optimized sample processing, library preparation, sequencing, and bioinformatics analysis, enabling researchers to obtain accurate, reproducible, and comprehensive insights into microbial communities with reduced hands-on time and operational complexity.What Are Latest Mergers And Acquisitions In The Metagenomics Market?
In March 2024, Clinical Microbiomics A/S, a Denmark-based microbiome science company, acquired DNASense ApS for an undisclosed amount. Through this acquisition, Clinical Microbiomics aims to enhance its metagenomic and long-read DNA/RNA sequencing capabilities and deepen its bioinformatics services for microbiome research and diagnostics. DNASense ApS is a Denmark-based CRO company that provides metagenomics services, specializing in long-read DNA and RNA sequencing technologies for microbiome analysis.Regional Outlook
North America was the largest region in the global metagenomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Metagenomics Market?
The metagenomics market consists of revenues earned by entities by providing metagenomic services such as meta transcriptome sequencing, microbial genome sequencing, functional analysis, comparative metagenomics, and meta transcriptomics services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Metagenomics Market Report 2026?
The metagenomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the metagenomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Metagenomics Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.65 billion |
| Revenue Forecast In 2035 | $4.58 billion |
| Growth Rate | CAGR of 14.5% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Workflow, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Illumina Inc., Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Novogene Co. Ltd., Oxford Nanopore Technologies Limited, BGI Group, Eurofins Scientific SE, Arc Bio LLC, Computomics GmbH, Enterome Bioscience, TAKARA BIO INC., Danaher Corporation, ELITechGroup, Metagenomi, Cosmosid Inc., Pattern Ag, Tiny Health, MATIS OHF, Adapsyn Bioscience, Precidiag Inc., One Codex Inc., MetaBi Inc., Zymo Research Corporation, Bluebee Holding BV, Maverix Biomics Inc., Lucigen Corporation |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Metagenomics market was valued at $2.31 billion in 2025, increased to $2.65 billion in 2026, and is projected to reach $4.58 billion by 2030.
request a sample hereThe global Metagenomics market is expected to grow at a CAGR of 14.7% from 2026 to 2035 to reach $4.58 billion by 2035.
request a sample hereSome Key Players in the Metagenomics market Include, Illumina Inc., Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Novogene Co. Ltd., Oxford Nanopore Technologies Limited, BGI Group, Eurofins Scientific SE, Arc Bio LLC, Computomics GmbH, Enterome Bioscience, TAKARA BIO INC., Danaher Corporation, ELITechGroup, Metagenomi, Cosmosid Inc., Pattern Ag, Tiny Health, MATIS OHF, Adapsyn Bioscience, Precidiag Inc., One Codex Inc., MetaBi Inc., Zymo Research Corporation, Bluebee Holding BV, Maverix Biomics Inc., Lucigen Corporation .
request a sample hereMajor trend in this market includes: Advancements In Human Microbiome Sequencing Enable Fully Automated, High-Throughput Analysis. For further insights on this market.
request a sample hereNorth America was the largest region in the global metagenomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metagenomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here